BioSpring and Phenion receive BMBF-Funding for the development of a bioactive for skin treatment
05-Aug-2005
During the project oligonucleotide molecules will be synthesized and characterized regarding to their biological activity in the skin within the Phenion®-Full Thickness Skin Model. For further development of suitable oligonucleotides the companies will search a strategic partnership e.g. with the pharmaceutical industry.
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.